Nextrials' Prism Achieves Compliance Certification
San Ramon, CA-April 6, 2009-
Administered by the American National Standards Institute (ANSI), HITSP is a cooperative effort with strategic partners such as the Healthcare Information and Management Systems Society (HIMSS), Integrating the Healthcare Enterprise (IHE), Advanced Technology Institute (ATI) and Booz Allen Hamilton.
Nextrials is again demonstrating Prism’s interoperability at the HIMSS 2009 Interoperability Showcase, part of the 2009 Annual Healthcare Information and Management Systems Society’s Conference & Exhibition, being held April 4-8 in Chicago. Conference attendees can find the showcase in Booth 7750 in the North Hall of McCormick Place.
“Nextrials has dedicated a significant amount of time toward support for ANSI’s work to promote the development and adoption of HITSP standards,” explained James Rogers, CEO and co-founder of Nextrials. “As an early implementer of HITSP interoperability specifications, we recognize the value of integrating electronic health records within clinical trial management systems, which will advance the continuum of patient care and further future clinical research.”
Nextrials’ award-winning Prism melds sophisticated clinical trial management functionality with electronic data capture in a single, integrated package. It is currently used worldwide by biopharmaceutical and medical device R&D teams developing novel treatments and therapeutics.
About Nextrials
Founded by pharmaceutical researchers in 1999, Nextrials offers today’s most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025